Since providing the world’s first injection system more than 90 years ago, we have been committed to making diabetes drug delivery as simple as possible.

At Novo Nordisk, we strive to understand the everyday needs of people with diabetes with the aim of developing injection pens and needles that ease the burden and meet the diverse needs of millions of people living with the disease.

NovoFine Plus needle laying on wooden table.

  • 32G needles are associated with less pain compared to thicker* needles1
  • 4 mm needles are associated with less risk of intramuscular injections compared to 6 mm needles
  • Designed with SuperFlowTM Technology which results in better flow compared to thin walled needles3
  • Compatible with most pen devices4
  • Unique needle design to reduce the risk of bending or breaking5
  • 4 mm length is suitable for subcutaneous delivery, regardless of BMI6

*thicker needles include 27G, 28G, 30G, #31G

1. Arendt-Nielsen L et al. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37–43.

2. Birkebaek NH et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care. 2008;31(9):e65.

3. NovoFine plus: DVT report.

4. NovoFine plus: DVT report.

5. NovoFine plus: DVT report.

6. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-55. #Yamada, 1967-PO 66th Annual Meeting and Scientific Sessions of the American Diabetes Association, 2006.

Novofine needle laying on table with needle-cap taken off.

  • 32G needles are associated with less pain compared to thicker* needles1
  • 4 mm needles are associated with less risk of intramuscular injections compared to 6 mm needles2
  • Unique needle design to reduce the risk of bending or breaking3
  • 4 mm length is suitable for subcutaneous delivery, regardless of BMI4
  • Compatible with most pen devices to simplify use5

*thicker needles include 27G, 28G, 30G, #31G

1. Arendt-Nielsen L et al. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37–43.

2. Birkebaek NH et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care. 2008;31(9): e65.

3. NovoFine DVT report.

4.Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-55.

5. NovoFine DVT report. #Yamada, 1967-PO 66th Annual Meeting and Scientific Sessions of the American Diabetes Association, 2006.

NovoTwist needle held in hand.

  • 32G needle reduces pain as compared to 28,29,30, #31G needles1
  • NovoTwist® is preferred by 3 out of 4 users due to its “just twist” technique, as compared to conventional screw thread needles2

1. Arendt-Nielsen L et al. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37-43.

2. Hansen B, Lilleøre SK, Ter-Borch G., Needle with a novel attachment versus conventional. Diabetes Technol Ther. 2011; 13:579-85. #Yamada, 1967-PO 66th Annual Meeting and Scientific Sessions of the American Diabetes Association, 2006